NCT00171275已完成4 期
Fluvastatin in the Therapy of Acute Coronary Syndrome
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Novartis
- 入组人数
- 1,000
- 试验地点
- 2
- 主要终点
- Change from baseline in circulating markers of inflammation after 4 weeks and after 52 weeks
研究概览
简要总结
This study is to evaluate the safety and efficacy of fluvastatin versus placebo, dosed shortly after or immediately when the coronary event occurs.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Acute coronary syndrome
- •Adults, 18 years and older
排除标准
- •History of lipid lowering therapy less than 30 days before index event
- •Pregnancy and nursing
- •Subject younger than 18 years
- •Other inclusion and exclusion criteria may apply.
结局指标
主要结局
Change from baseline in circulating markers of inflammation after 4 weeks and after 52 weeks
次要结局
- Occurrence of death, nonfatal myocardial infarction, cardiac arrest with resuscitation, recurrent symptomatic ischemia, and urgent revascularization after 4 weeks and after 52 weeks
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Fluvastatin in the therapy of acute coronary syndromeAcute coronary syndrome (ACS)Circulatory SystemCoronary diseasesISRCTN81331696ovartis Pharma CR s.r.o.1,000
已完成
2 期
Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome PatientsAntiphospholipid SyndromeNCT00674297Hospital for Special Surgery, New York41
已完成
4 期
Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)Actue Coronary SyndromesNCT00382460Bristol-Myers Squibb4,000
尚未招募
4 期
Collaborative Trial of Fluvastatin on Atrial FibrillatioJPRN-UMIN000000582CO-FAT study group300
已完成
4 期
Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients TransplantGraft VasculopathyNCT00565474Novartis Pharmaceuticals84